Skip to main content

Pravin Anand and Neeti Wilson look at the workings of intellectual property rights in the life sciences industry.

An in-depth look into the interaction between intellectual property rights and the protection of small molecules , particularly in the pharmaceutical sector, second-generation inventions, DNA, and biological and personalised medicine. The chapter also looks at the intricacies of compulsory licensing, patent infringement and enforcement.

Protection of patent also requires ascertaining ownership and compensation, and the ancillary IP involved in protecting branding and designs.

This chapter was published in IP in the Life Sciences.

To continue reading, please contact us at email@anandandanand.com

Most Recent

News & Insights

VIEW ALL
News & Updates
Aug 25, 2025

At the FICCI–ICRIER Conference on SEPs (23rd August 2025), our Managing Partner Mr. Pravin Anand shared his vision on how India can evolve from being

Conference on Standard Essential Patents (SEPs)
News & Updates
Aug 24, 2025

‘Intellectual Property for a company/ creator is as critical and important as human rights for an individual,’ this guiding belief at ANAND AND ANAND

IAM Strategy 300
Thought Leadership
Aug 21, 2025

‘First published on IAM’ By:  Vaishali R Mittal Patent examination by the Indian Patent Office (IPO) has slowed down dramatically over the last few

Patent examination slowdown risks harming India’s IP momentum
Thought Leadership
Jul 28, 2025

‘First published on Asia IP’ By: Pravin Anand In the book What is Life, written in 1944 by theoretical physicist Erwin Schrödinger, the author states: “A

Human versus machine consciousness